Showing 91-100 of 3101 results for "".
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31110/Adrenal insufficiency remains a significant clinical concern, particularly in patients undergoing long-term glucocorticoid therapy for conditions such as multiple sclerosis (MS). A pertinent case involves a 54-year-old woman with a decade-long history of primary progressive MS, managed with monthly
Atypical Patients with Typical Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0209_02-php/30945/Shifting epidemiological trends suggest that common perceptions of the "typical" MS patient may no longer be accurate.Multiple Sclerosis: Expanding the Field Beyond Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-expanding-the-field-beyond-management/31972/This issue provides a tour through a seemingly ever-expanding universe of applicable data on MS.Seeking Breakthroughs: The Physician Perspective
https://practicalneurology.com/columns/practice-management/the-physician-perspective/30193/A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhD- Expert Opinionhttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0305ExpertOpinion-pdf/31480/Does “Benign” Multiple Sclerosis Really Exist? A Clinical AnalysisIn the March 2005 issue of *Practical Neurology*, Dr. George G. Hutton provides an expert opinion on the existence and diagnosis of benign multiple sclerosis (MS) through the examination of a 53-year-old male patient. The case centers
- Detecting Subtle Multiple Sclerosis Mimickershttps://practicalneurology.com/columns/practice-management/detecting-subtle-multiple-sclerosis-mimickers/31415/Differentiating Multiple Sclerosis from Its Mimicking Conditions: A Comprehensive OverviewDiagnosing multiple sclerosis (MS) remains one of the most challenging tasks in neurology due to the existence of over 100 conditions that can present with similar clinical features. While general practitioners
Expanding the Scope of Neurology: An Interview with Ralph L. Sacco, MD
https://practicalneurology.com/columns/practice-management/expanding-the-scope-of-neurology-an-interview-with-ralph-l-sacco-md/30358/New AAN President sees collaboration and wellness as integral to the future of the specialty.- What Will Be Tysabri's Fate?https://practicalneurology.com/columns/practice-management/what-will-be-tysabris-fate/31328/Natalizumab (Tysabri) in Multiple Sclerosis: Breakthroughs and ChallengesOver the past decades, advancements in understanding multiple sclerosis (MS) pathogenesis have paved the way for targeted therapies aimed at disrupting the inflammatory processes that drive central nervous system (CNS) inflamma
Parkinson's Disease: Disease Modifying Therapies Remain Elusive
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinsons-disease-disease-modifying-therapies-remain-elusive/30604/Insights from Zoltan Mari, MD- Keeping Tysabri Therapy on Targethttps://practicalneurology.com/columns/practice-management/keeping-tysabri-therapy-on-target/31170/Natalizumab (Tysabri) in Multiple Sclerosis: Balancing Efficacy and SafetyOne year following its reintroduction to the market, natalizumab (Tysabri) continues to be a focal point for multiple sclerosis (MS) specialists striving to optimize its use while mitigating associated risks. Originally withdr